Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02573883 · ClinicalTrials.gov registry record · Phase 3
Clobetasol Propionate Versus Fractionated Carbon Dioxide Laser for the Treatment of Lichen Sclerosus
A Phase 3 study, sponsored by Medstar Health Research Institute.
- Completed
- Registry status
- Phase 3
- Development phase
- 52
- Enrollment target
NCT02573883 is a Phase 3 study that has completed, run by Medstar Health Research Institute. The registered enrollment target is 52 participants.
The verdict
NCT02573883, a Phase 3 study, has completed, sponsored by Medstar Health Research Institute.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 52 participants
- Enrollment target
Study Summary
This study is being done to compare the effects, good and bad, of fractionated CO2 laser treatment and clobetasol propionate .05% ointment on vulvar lichen sclerosus.
Interventions
- DEVICE Fractionated Carbon Dioxide Laser
- DRUG Clobetasol Propionate 0.05% ointment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2015-10 |
| Est. Completion | 2019-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02573883
The ClinicalTrials.gov registry entry for NCT02573883 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medstar Health Research Institute, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Fractionated Carbon Dioxide Laser is the first listed.
NCT02573883 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02573883 about?
NCT02573883 is a clinical study titled "Clobetasol Propionate Versus Fractionated Carbon Dioxide Laser for the Treatment of Lichen Sclerosus". This study is being done to compare the effects, good and bad, of fractionated CO2 laser treatment and clobetasol propionate .05% ointment on vulvar lichen sclerosus.
What is the current status of trial NCT02573883?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 52 participants. The study started on 2015-10. Estimated completion is 2019-09.
What interventions are being tested in trial NCT02573883?
The interventions under investigation include: Fractionated Carbon Dioxide Laser (DEVICE), Clobetasol Propionate 0.05% ointment (DRUG).
Who is sponsoring clinical trial NCT02573883?
This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.